Argenta, a Galapagos NV company that provides drug discovery services, has signed a collaboration agreement with Pcovery to provide medicinal chemistry and computer-aided drug design services to assist Pcovery in the identification of anti-fungal agents for clinical development. The collaboration is being funded by a Wellcome Trust Seeding Drug Discovery (SDD) award.
 
Dr. John Montana, managing director of Argenta said, “Argenta is pleased to announce this collaboration with Pcovery, which represents the third Wellcome Trust SDD-funded project aided by Argenta during the funding rounds in 2012. The Argenta team looks forward to working with Pcovery towards achieving the project goals over the coming months”.
 
Casper Tind Hansen, chief executive officer of Pcovery said, “We look forward very much to working with the highly skilled and capable Argenta team to progress what will hopefully be a novel class of anti-fungal drugs for invasive fungal infections. The Argenta team has already been a big help in securing the Wellcome Trust SDD funding.”